Journal articles on the topic 'P14ARF'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'P14ARF.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Cilluffo, Danilo, Viviana Barra, and Aldo Di Leonardo. "P14ARF: The Absence that Makes the Difference." Genes 11, no. 7 (July 20, 2020): 824. http://dx.doi.org/10.3390/genes11070824.
Full textEymin, Béatrice, Paule Claverie, Caroline Salon, Camille Leduc, Edwige Col, Elisabeth Brambilla, Saadi Khochbin, and Sylvie Gazzeri. "p14ARF Activates a Tip60-Dependent and p53-Independent ATM/ATR/CHK Pathway in Response to Genotoxic Stress." Molecular and Cellular Biology 26, no. 11 (June 1, 2006): 4339–50. http://dx.doi.org/10.1128/mcb.02240-05.
Full textHe, Mingwei, Jinlei Pang, Haiyan Sun, Guanrong Zheng, Yan Lin, and Weipeng Ge. "P14ARF inhibits regional inflammation and vascularization in intervertebral disc degeneration by upregulating TIMP3." American Journal of Physiology-Cell Physiology 318, no. 4 (April 1, 2020): C751—C761. http://dx.doi.org/10.1152/ajpcell.00271.2019.
Full textShamanin, Vladimir A., and Elliot J. Androphy. "Immortalization of Human Mammary Epithelial Cells Is Associated with Inactivation of the p14ARF-p53 Pathway." Molecular and Cellular Biology 24, no. 5 (March 1, 2004): 2144–52. http://dx.doi.org/10.1128/mcb.24.5.2144-2152.2004.
Full textCho, E. Y., Y. L. Choi, S. W. Chae, J. H. Sohn, and G. H. Ahn. "Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms." International Journal of Gynecologic Cancer 16, no. 3 (2006): 1000–1006. http://dx.doi.org/10.1136/ijgc-00009577-200605000-00008.
Full textSánchez-Aguilera, Abel, Margarita Sánchez-Beato, Juan F. Garcı́a, Ignacio Prieto, Marina Pollan, and Miguel A. Piris. "p14ARF nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways." Blood 99, no. 4 (February 15, 2002): 1411–18. http://dx.doi.org/10.1182/blood.v99.4.1411.
Full textOlcha, Piotr, Marek Cybulski, Danuta Skomra, Bogdan Obrzut, Atanas Ignatov, Maciej Jóźwik, Regine Schneider-Stock, and Andrzej Semczuk. "The Pattern of p14ARF Expression in Primary and Metastatic Human Endometrial Carcinomas." International Journal of Gynecologic Cancer 20, no. 6 (July 2010): 993–99. http://dx.doi.org/10.1111/igc.0b013e3181e76a4d.
Full textSong, Joon Seon, Joo Mi Yi, Hanbyoul Cho, Chel Hun Choi, Yoonho Park, Eun Joo Chung, Jaewhan Song, Joon-Yong Chung, and Seung-Mo Hong. "Dual loss of USP10 and p14ARF protein expression is associated with poor prognosis in patients with small intestinal adenocarcinoma." Tumor Biology 40, no. 10 (October 30, 2018): 101042831880867. http://dx.doi.org/10.1177/1010428318808678.
Full textMartinez, Juan Carlos, Santiago Ropero, Concepcion Mateos, Maria DEL VAL Toledo, Rafael Samaniego, Silvia Sacristan, and Manel Esteller. "Alteration of the p53 and Rb tumor suppressor pathways by p16/INK4a and p14/ARF promoter methylation and loss of protein expression in recurrent and nonrecurrent meningiomas." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 2064. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2064.
Full textBai, Ming, Nan-Ze Yu, Fei Long, Cheng Feng, and Xiao-Jun Wang. "Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells." Cellular Physiology and Biochemistry 40, no. 6 (2016): 1367–76. http://dx.doi.org/10.1159/000453189.
Full textKordi-Tamandani, Dor Mohammad, Abdolkarim Moazeni-Roodi, Mohammad Ayoub Rigi Ladez, Mohammad Hashemi, Elnaz Birjandian, and Adam Torkamanzehi. "Analysis of Methylation Patterns and Expression Profiles of P14Arf Gene in Patients with Oral Squamous Cell Carcinoma." International Journal of Biological Markers 25, no. 2 (April 2010): 99–103. http://dx.doi.org/10.1177/172460081002500207.
Full textShen, Jia, Shengping Zhang, Yang Li, Wen Zhang, Jiandong Chen, Mary Zhang, Ting Wang, et al. "p14ARF inhibits the functions of adenovirus E1A oncoprotein." Biochemical Journal 434, no. 2 (February 11, 2011): 275–85. http://dx.doi.org/10.1042/bj20101163.
Full textHuang, Hsuan-Ying, Peter B. Illei, Zhiquan Zhao, Madhu Mazumdar, Andrew G. Huvos, John H. Healey, Leonard H. Wexler, Richard Gorlick, Paul Meyers, and Marc Ladanyi. "Ewing Sarcomas Withp53Mutation orp16/p14ARFHomozygous Deletion: A Highly Lethal Subset Associated With Poor Chemoresponse." Journal of Clinical Oncology 23, no. 3 (January 20, 2005): 548–58. http://dx.doi.org/10.1200/jco.2005.02.081.
Full textCisneros, José, James Hagood, Marco Checa, Blanca Ortiz-Quintero, Miguel Negreros, Iliana Herrera, Carlos Ramos, Annie Pardo, and Moisés Selman. "Hypermethylation-mediated silencing of p14ARF in fibroblasts from idiopathic pulmonary fibrosis." American Journal of Physiology-Lung Cellular and Molecular Physiology 303, no. 4 (August 15, 2012): L295—L303. http://dx.doi.org/10.1152/ajplung.00332.2011.
Full textPalrasu, Manikandan, Elena Zaika, El-Rifai Wael, Richard Peek, and Alexander Zaika. "Regulation of p14ARF by Siva1 in H. pylori-infected gastric epithelial cells." Journal of Clinical Oncology 39, no. 3_suppl (January 20, 2021): 243. http://dx.doi.org/10.1200/jco.2021.39.3_suppl.243.
Full textKozik, Bojana, Milena Krajnovic, Nikola Kokanov, Snezana Jovanovic-Cupic, Ana Bozovic, Lidija Todorovic, and Vesna Mandusic. "Combined analysis of KARS mutation and p16INK4a and p14ARF methylation status in locally advanced rectal carcinoma treated with preoperative chemoradiotherapy." Archives of Biological Sciences, no. 00 (2022): 11. http://dx.doi.org/10.2298/abs220222011k.
Full textde Almeida Simão, Tatiana, Gabriela Loureiro De Bonis Almeida Simões, Fabiana Siqueira Ribeiro, Daniela Anhel de Paula Cidade, Nelson Adami Andreollo, Luiz Roberto Lopes, Jacyara Maria Brito Macedo, et al. "Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas." Human & Experimental Toxicology 25, no. 9 (September 2006): 515–22. http://dx.doi.org/10.1191/0960327106het649oa.
Full textPaul, Esbjörn, Bertil Uggla, Kals G. Wiman, Christer Paul, Soren Lehmann, and Hareth Nahi. "Low Expression of p14ARF in De Novo AML with Normal Karyotype Is Associated with Short Survival but Increased in Vitro Sensitivity to p53 Modulating Drugs." Blood 112, no. 11 (November 16, 2008): 2937. http://dx.doi.org/10.1182/blood.v112.11.2937.2937.
Full textDimri, Goberdhan P., Koji Itahana, Meileen Acosta, and Judith Campisi. "Regulation of a Senescence Checkpoint Response by the E2F1 Transcription Factor and p14ARF Tumor Suppressor." Molecular and Cellular Biology 20, no. 1 (January 1, 2000): 273–85. http://dx.doi.org/10.1128/mcb.20.1.273-285.2000.
Full textTomicic, Maja T., Franziska Krämer, Alexandra Nguyen, Christian Schwarzenbach, and Markus Christmann. "Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14ARF-Mediated Sustained p53 Activation." Cancers 13, no. 9 (April 22, 2021): 2019. http://dx.doi.org/10.3390/cancers13092019.
Full textPaul, Esbjorn O., Stefan Deneberg, Soren Lehmann, Sofia Bengtzén, and Hareth Nahi. "Expression of p14ARF in De Novo AML with Normal Karyotype. Implication on Drug Resistance and Survival." Blood 110, no. 11 (November 16, 2007): 4261. http://dx.doi.org/10.1182/blood.v110.11.4261.4261.
Full textMason, Sarah L., Öonagh Loughran, and Nicholas B. La Thangue. "p14ARF regulates E2F activity." Oncogene 21, no. 27 (June 2002): 4220–30. http://dx.doi.org/10.1038/sj.onc.1205524.
Full textEdwards, Sara J., Brett R. Dix, Colleen J. Myers, Deirdre Dobson-Le, Lily Huschtscha, Merilyn Hibma, Janice Royds, and Antony W. Braithwaite. "Evidence that Replication of the Antitumor Adenovirus ONYX-015 Is Not Controlled by the p53 and p14ARF Tumor Suppressor Genes." Journal of Virology 76, no. 24 (December 15, 2002): 12483–90. http://dx.doi.org/10.1128/jvi.76.24.12483-12490.2002.
Full textIvanchuk, S., S. Mondal, and J. Rutka. "Identifying novel p14ARF binding partners." European Journal of Cancer 37 (April 2001): S122. http://dx.doi.org/10.1016/s0959-8049(01)80938-2.
Full textMing, Zizhen, Su Yin Lim, and Helen Rizos. "Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression." Biomolecules 10, no. 10 (October 15, 2020): 1447. http://dx.doi.org/10.3390/biom10101447.
Full textCalabrò, Viola, Gelsomina Mansueto, Raffaela Santoro, Antonio Gentilella, Alessandra Pollice, Pamela Ghioni, Luisa Guerrini, and Girolama La Mantia. "Inhibition of p63 Transcriptional Activity by p14ARF: Functional and Physical Link between Human ARF Tumor Suppressor and a Member of the p53 Family." Molecular and Cellular Biology 24, no. 19 (October 1, 2004): 8529–40. http://dx.doi.org/10.1128/mcb.24.19.8529-8540.2004.
Full textGjerset, Ruth A., and Keya Bandyopadhyay. "Regulation of p14ARF Through Subnuclear Compartmentalization." Cell Cycle 5, no. 7 (March 28, 2006): 686–90. http://dx.doi.org/10.4161/cc.5.7.2623.
Full textDobrowolski, Rafael, Rüdiger Hein, Reinhard Buettner, and Anja Bosserhoff. "Loss of p14ARF expression in melanoma." Archives of Dermatological Research 293, no. 11 (November 27, 2001): 545–51. http://dx.doi.org/10.1007/s00403-001-0274-y.
Full textLee, Casey, Brian A. Smith, Keya Bandyopadhyay, and Ruth A. Gjerset. "DNA Damage Disrupts the p14ARF-B23(Nucleophosmin) Interaction and Triggers a Transient Subnuclear Redistribution of p14ARF." Cancer Research 65, no. 21 (November 1, 2005): 9834–42. http://dx.doi.org/10.1158/0008-5472.can-05-1759.
Full textWang, Yu-Chien, Ruo-Kai Lin, Yi-Hung Tan, Jung-Ta Chen, Chih-Yi Chen, and Yi-Ching Wang. "Wild-Type p53 Overexpression and Its Correlation With MDM2 and p14ARF Alterations: An Alternative Pathway to Non–Small-Cell Lung Cancer." Journal of Clinical Oncology 23, no. 1 (January 1, 2005): 154–64. http://dx.doi.org/10.1200/jco.2005.03.139.
Full textSok, Vanessa, Alec Z. Jacinto, Natalie Peng, Mohamed Eldemerdash, Lysa Le, Philip D. Tran, Li Feng Feng, et al. "G protein coupled receptor kinase 5 modifies the nucleolar stress response activated by actinomycin D." Biochemistry and Cell Biology 99, no. 4 (August 2021): 508–18. http://dx.doi.org/10.1139/bcb-2020-0480.
Full textKowalczyk, Dominika, Mark A. Nakasone, Brian O. Smith, and Danny T. Huang. "Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function." Life Science Alliance 5, no. 12 (August 9, 2022): e202201472. http://dx.doi.org/10.26508/lsa.202201472.
Full textMuñoz, Jorge, María del Mar Inda, Paula Lázcoz, Idoya Zazpe, Xing Fan, Jorge Alfaro, Teresa Tuñón, Juan A. Rey, and Javier S. Castresana. "Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas." ISRN Neurology 2012 (January 9, 2012): 1–10. http://dx.doi.org/10.5402/2012/576578.
Full textShamanin, Vladimir A., Pedja Sekaric, and Elliot J. Androphy. "hAda3 Degradation by Papillomavirus Type 16 E6 Correlates with Abrogation of the p14ARF-p53 Pathway and Efficient Immortalization of Human Mammary Epithelial Cells." Journal of Virology 82, no. 8 (February 6, 2008): 3912–20. http://dx.doi.org/10.1128/jvi.02466-07.
Full textTian, Kai-hua, Yi Shen, Yi-rne Luo, Ming-zhao Wang, Hong-xu Liu, Hui-ru Zhao, and Lin Zhang. "Hypermethylation of p14ARF promoter region and expresion of p14ARF gene product in non-small cell lung cancer." Chinese Journal of Cancer Research 18, no. 4 (December 2006): 276–81. http://dx.doi.org/10.1007/s11670-006-0276-6.
Full textBlanco-Luquin, Idoia, Paula Lázcoz, Jon Celay, Javier S. Castresana, and Ignacio J. Encío. "In Vitro Assessment of the Role of p53 on Chemotherapy Treatments in Neuroblastoma Cell Lines." Pharmaceuticals 14, no. 11 (November 19, 2021): 1184. http://dx.doi.org/10.3390/ph14111184.
Full textItahana, Koji, and Yanping Zhang. "Mitochondrial targeting signals: Another barcode in p14ARF?" Cell Cycle 9, no. 5 (March 2010): 861–69. http://dx.doi.org/10.4161/cc.9.5.11039.
Full textMcCormick, Frank. "ONYX-015 selectivity and the p14ARF pathway." Oncogene 19, no. 56 (December 2000): 6670–72. http://dx.doi.org/10.1038/sj.onc.1204096.
Full textAnzola, Monica, Nerea Cuevas, Monica L??pez-Mart??nez, Alberto Saiz, Juan Jos?? Burgos, and Marian Mart??nez de Pancorbo. "p14ARF gene alterations in human hepatocellular carcinoma." European Journal of Gastroenterology & Hepatology 16, no. 1 (January 2004): 19–26. http://dx.doi.org/10.1097/00042737-200401000-00004.
Full textHuang, Yinghui, Christopher J. Peters, Rebecca C. Fitzgerald, and Ruth A. Gjerset. "Progressive silencing of p14ARF in oesophageal adenocarcinoma." Journal of Cellular and Molecular Medicine 13, no. 2 (April 10, 2008): 398–409. http://dx.doi.org/10.1111/j.1582-4934.2008.00336.x.
Full textKashuba, Elena, Karin Mattsson, Katja Pokrovskaja, Csaba Kiss, Marina Protopopova, Barbro Ehlin-Henriksson, George Klein, and Laszlo Szekely. "EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells." International Journal of Cancer 105, no. 5 (May 5, 2003): 644–53. http://dx.doi.org/10.1002/ijc.11124.
Full textMa, Hanhui, and Thoru Pederson. "Depletion of the Nucleolar Protein Nucleostemin Causes G1 Cell Cycle Arrest via the p53 Pathway." Molecular Biology of the Cell 18, no. 7 (July 2007): 2630–35. http://dx.doi.org/10.1091/mbc.e07-03-0244.
Full textMaitra, Anirban, Helen Roberts, Arthur G. Weinberg, and Joseph Geradts. "Aberrant Expression of Tumor Suppressor Proteins in the Ewing Family of Tumors." Archives of Pathology & Laboratory Medicine 125, no. 9 (September 1, 2001): 1207–12. http://dx.doi.org/10.5858/2001-125-1207-aeotsp.
Full textHemmati, Philipp G., Guillaume Normand, Berlinda Verdoodt, Clarissa von Haefen, Anne Hasenjäger, Dilek Güner, Jana Wendt, Bernd Dörken, and Peter T. Daniel. "Loss of p21 disrupts p14ARF-induced G1 cell cycle arrest but augments p14ARF-induced apoptosis in human carcinoma cells." Oncogene 24, no. 25 (March 7, 2005): 4114–28. http://dx.doi.org/10.1038/sj.onc.1208579.
Full textZhuang, Wen-yue, and Zi-Xing Chen. "Epigenetic Silencing of Bcl-2, C/Ebpa and p14ARF by the AML1/ETO Oncoprotein Contributing to Growth Arrest and Differentiation Blockage." Blood 116, no. 21 (November 19, 2010): 3617. http://dx.doi.org/10.1182/blood.v116.21.3617.3617.
Full textXiong, Chao-Liang, and Yuan Huang. "Methylation and expression of p14ARF in colorectal cancer." World Chinese Journal of Digestology 18, no. 8 (2010): 786. http://dx.doi.org/10.11569/wcjd.v18.i8.786.
Full textBadal, Vinay, Sergio Ménendez, David Coomber, and David P. Lane. "Regulation of the p14ARF promoter by DNA methylation." Cell Cycle 7, no. 1 (January 2008): 112–19. http://dx.doi.org/10.4161/cc.7.1.5137.
Full textTaniguchi, T., N. Chikatsu, S. Takahashi, A. Fujita, K. Uchimaru, S. Asano, T. Fujita, and T. Motokura. "Expression of p16INK4A and p14ARF in hematological malignancies." Leukemia 13, no. 11 (November 1999): 1760–69. http://dx.doi.org/10.1038/sj.leu.2401557.
Full textLee, Y. K., J.-Y. Park, H. J. Kang, and H. C. Cho. "Overexpression of p16INK4A and p14ARF in haematological malignancies." Clinical & Laboratory Haematology 25, no. 4 (July 23, 2003): 233–37. http://dx.doi.org/10.1046/j.1365-2257.2003.00520.x.
Full textBates, Stewart, Andrew C. Phillips, Paula A. Clark, Francesca Stott, Gordon Peters, Robert L. Ludwig, and Karen H. Vousden. "p14ARF links the tumour suppressors RB and p53." Nature 395, no. 6698 (September 1998): 124–25. http://dx.doi.org/10.1038/25867.
Full text